Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Odom

Showing results (201-210 of 206) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 206 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patientsJ Y Wong, D Z Chu, D Yamauchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 1998
Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibodyJ Y Wong, G E Thomas, D Yamauchi, et al.
Molecular Therapy. Methods & Clinical Development|March 6, 2023
Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy modelArden B Piepho, Jeovanna Lowe, Laurel R Cumby, et al.
Human Molecular Genetics|August 2, 2014
Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wastingKristy Swiderski, Scott A Shaffer, Byron Gallis, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Cell based dATP delivery as a therapy for chronic heart failureKetaki N Mhatre, Julie Mathieu, Amy Martinson, et al.
Cancer Treatment Reports|February 1, 1983
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant gliomaS B Green, D P Byar, M D Walker, et al.
Pageof 21

Showing results (201-210 of 206) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patientsJ Y Wong, D Z Chu, D Yamauchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 1998
Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibodyJ Y Wong, G E Thomas, D Yamauchi, et al.
Molecular Therapy. Methods & Clinical Development|March 6, 2023
Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy modelArden B Piepho, Jeovanna Lowe, Laurel R Cumby, et al.
Human Molecular Genetics|August 2, 2014
Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wastingKristy Swiderski, Scott A Shaffer, Byron Gallis, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Cell based dATP delivery as a therapy for chronic heart failureKetaki N Mhatre, Julie Mathieu, Amy Martinson, et al.
Cancer Treatment Reports|February 1, 1983
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant gliomaS B Green, D P Byar, M D Walker, et al.
Pageof 21